Cargando…

Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)

Detalles Bibliográficos
Autores principales:	Neubauer, Andreas, Wiesmann, Thomas, Vogelmeier, Claus F., Mack, Elisabeth, Skevaki, Chrysanthi, Gaik, Christine, Keller, Christian, Figiel, Jens, Sohlbach, Kristina, Rolfes, Caroline, Renz, Harald, Wulf, Hinnerk, Burchert, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298698/ https://www.ncbi.nlm.nih.gov/pubmed/32555296 http://dx.doi.org/10.1038/s41375-020-0907-9

Ejemplares similares

The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
por: Neubauer, Andreas, et al.
Publicado: (2021)

Publisher Correction: The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
por: Neubauer, Andreas, et al.
Publicado: (2021)

Serum proteomics hint at an early T-cell response and modulation of SARS-CoV-2-related pathogenic pathways in COVID-19-ARDS treated with Ruxolitinib
por: Völkel, Sara, et al.
Publicado: (2023)

Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?
por: Pusch, Emanuel, et al.
Publicado: (2018)

Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?
por: Pusch, Emanuel, et al.
Publicado: (2018)

The Benefit of Benzodiazepine Reduction: Improving Sedation in Surgical Intensive Care
por: Schneider, Ralph, et al.
Publicado: (2017)

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
por: Caocci, Giovanni, et al.
Publicado: (2020)

Asthma-associated risk for COVID-19 development
por: Skevaki, Chrysanthi, et al.
Publicado: (2020)

Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus
por: Skevaki, Chrysanthi, et al.
Publicado: (2020)

Severe ARDS due to Ruxolitinib discontinuation syndrome: case presentation and literature review
por: Houthuys, Jona F., et al.
Publicado: (2022)

Recommendations for anesthesia and perioperative management in patients with Ehlers-Danlos syndrome(s)
por: Wiesmann, Thomas, et al.
Publicado: (2014)

Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015
por: Wiesmann, Thomas, et al.
Publicado: (2019)

Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses
por: Balz, Kathrin, et al.
Publicado: (2020)

Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses
por: Balz, Kathrin, et al.
Publicado: (2021)

Cross-reactive MHC class I T cell epitopes may dictate heterologous immune responses between respiratory viruses and food allergens
por: Balz, Kathrin, et al.
Publicado: (2023)

SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship
por: Skevaki, Chrysanthi, et al.
Publicado: (2021)

Effect of bupivacaine and adjuvant drugs for regional anesthesia on nerve tissue oximetry and nerve blood flow
por: Wiesmann, Thomas, et al.
Publicado: (2018)

Effect of bupivacaine and adjuvant drugs on skeletal muscle tissue oximetry and blood flow: an experimental study
por: Schubert, Ann-Kristin, et al.
Publicado: (2019)

Perioperative Schmerztherapie bei minimal-invasiver Thoraxchirurgie
por: Bach, Katharina, et al.
Publicado: (2023)

Gardening can induce pulmonary failure: Aspergillus ARDS in an immunocompetent patient, a case report
por: Jung, Nina, et al.
Publicado: (2014)

Supplemental Interscalene Blockade to General Anesthesia for Shoulder Arthroscopy: Effects on Fast Track Capability, Analgesic Quality, and Lung Function
por: Zoremba, Martin, et al.
Publicado: (2015)

Acute respiratory distress syndrome; A rare complication caused by usage of ruxolitinib
por: Kerget, Bugra, et al.
Publicado: (2017)

Respiratory viral co‐infections in patients with COVID‐19 and associated outcomes: A systematic review and meta‐analysis
por: Krumbein, Hanna, et al.
Publicado: (2022)

Activation of Group 2 Innate Lymphoid Cells via TL1A/DR3. A Solution to Corticosteroid Resistance?
por: Skevaki, Chrysanthi, et al.
Publicado: (2020)

Chlorhexidine Gluconate Dressings Reduce Bacterial Colonization Rates in Epidural and Peripheral Regional Catheters
por: Kerwat, Klaus, et al.
Publicado: (2015)

Programmed intermittent epidural bolus versus continuous epidural infusion for postoperative analgesia after major abdominal and gynecological cancer surgery: a randomized, triple-blinded clinical trial
por: Wiesmann, Thomas, et al.
Publicado: (2018)

Recovery and prediction of postoperative muscle power – is it still a problem?
por: Zoremba, Martin, et al.
Publicado: (2017)

Editorial: Early Life Origins of Immune-Mediated Disease
por: Skevaki, Chrysanthi, et al.
Publicado: (2020)

Antibody repertoire and autoimmunity
por: Skevaki, Chrysanthi, et al.
Publicado: (2023)

Ruxolitinib for myelofibrosis
por: GU, LIAN, et al.
Publicado: (2013)

Measles-induced respiratory distress, air-leak and ARDS
por: Piastra, M., et al.
Publicado: (2009)

Kratom-Induced Acute Respiratory Distress Syndrome (ARDS)
por: Chinnappan, Justine, et al.
Publicado: (2023)

Vitamin D supplementation for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials
por: Kümmel, Lara S., et al.
Publicado: (2022)

Antioxidants as Therapeutic Agents in Acute Respiratory Distress Syndrome (ARDS) Treatment—From Mice to Men
por: von Knethen, Andreas, et al.
Publicado: (2022)

Videolaryngoscopy versus direct laryngoscopy for double-lumen endotracheal tube intubation in thoracic surgery - a randomised controlled clinical trial
por: Risse, Joachim, et al.
Publicado: (2020)

Ruxolitinib: Thrombocytopenia following compassionate use of ruxolitinib: 2 case reports
Publicado: (2022)

Acute respiratory distress syndrome in a patient with primary myelofibrosis after ruxolitinib treatment discontinuation
por: Beauverd, Yan, et al.
Publicado: (2014)

Randomized Phase 3 Trial of Ruxolitinib for COVID-19–Associated Acute Respiratory Distress Syndrome*
por: Rein, Lindsay, et al.
Publicado: (2022)

Dantrolene versus amiodarone for cardiopulmonary resuscitation: a randomized, double-blinded experimental study
por: Wiesmann, Thomas, et al.
Publicado: (2017)

Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS)
por: Revercomb, Lucy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lf13agjprvod4u8l7p375cklbp